Amarin Corporation PLC Stock Trading Halted Today; FDA Advisory Committee to Review sNDA for Vascepa® ANCHOR Indication

Published: Oct 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J., and DUBLIN, Ireland, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that NASDAQ has halted trading of the company's shares.

Help employers find you! Check out all the jobs and post your resume.

Back to news